0000315066-13-003140.txt : 20130327 0000315066-13-003140.hdr.sgml : 20130327 20130327165324 ACCESSION NUMBER: 0000315066-13-003140 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130325 FILED AS OF DATE: 20130327 DATE AS OF CHANGE: 20130327 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TETRAPHASE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001373707 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 480 ARSENAL STREET STREET 2: SUITE 110 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617.715.3600 MAIL ADDRESS: STREET 1: 480 ARSENAL STREET STREET 2: SUITE 110 CITY: WATERTOWN STATE: MA ZIP: 02472 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FMR LLC CENTRAL INDEX KEY: 0000315066 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35837 FILM NUMBER: 13720542 BUSINESS ADDRESS: STREET 1: 245 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6175706339 MAIL ADDRESS: STREET 1: 245 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02210 FORMER NAME: FORMER CONFORMED NAME: FMR CORP DATE OF NAME CHANGE: 19920717 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2013-03-25 0 0001373707 TETRAPHASE PHARMACEUTICALS INC TTPH 0000315066 FMR LLC 245 SUMMER STREET BOSTON MA 02210 0 0 1 1 Edward C. Johnson 3d Common Stock 2013-03-25 4 C 0 1488699 A 2131556 I by Beacon Bioventures Limited Partnership Common Stock 2013-03-25 4 C 0 10089 A 2141645 I by Beacon Bioventures Principals Limited Partnership Series A-1 Convertible Preferred Stock 2013-03-25 4 C 0 2075931 D Common Stock 71584 0 I by Beacon Bioventures Limited Partnership Series A-2 Convertible Preferred Stock 2013-03-25 4 C 0 2707735 D Common Stock 93370 0 I by Beacon Bioventures Limited Partnership Series B Convertible Preferred Stock 2013-03-25 4 C 0 11345154 D Common Stock 391212 0 I by Beacon Bioventures Limited Partnership Series C Convertible Preferred Stock 2013-03-25 4 C 0 27043477 D Common Stock 932533 0 I by Beacon Bioventures Limited Partnership Series A-1 Convertible Preferred Stock 2013-03-25 4 C 0 14069 D Common Stock 485 0 I by Beacon Bioventures Principals Limited Partnership Series A-2 Convertible Preferred Stock 2013-03-25 4 C 0 18351 D Common Stock 633 0 I by Beacon Bioventures Principals Limited Partnership Series B Convertible Preferred Stock 2013-03-25 4 C 0 76891 D Common Stock 2651 0 I by Beacon Bioventures Principals Limited Partnership Series C Convertible Preferred Stock 2013-03-25 4 C 0 183283 D Common Stock 6320 0 I by Beacon Bioventures Principals Limited Partnership On March 25, 2013, in connection with the completion of the issuer's initial public offering, all shares of Convertible Preferred Stock were automatically converted into Common Stock at a ratio of 29:1. Beacon Bioventures Advisors Limited Partnership is the general partner of Beacon Bioventures Limited Partnership and Beacon Bioventures Principals Limited Partnership. Beacon Bioventures Advisors Limited Partnership is solely managed by Northern Neck Investors LLC, its general partner and investment manager. Northern Neck Investors LLC is owned, directly or indirectly, by various shareholders and employees of FMR LLC, including certain members of the family of Edward C. Johnson 3d. Scott C. Goebel, Duly authorized under Powers of Attorney effective as of June 1, 2008, by and on behalf of FMR LLC and its direct and indirect subsidiaries, and by and on behalf of Edward C. Johnson 3d 2013-03-27